Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- ‘We must act’: Physician burnout reaches ‘crisis levels’ in COVID-19 aftermath Rob Volansky; Robert Stott
-
- AGA recommends use of fecal calprotectin, serum CRP to inform Crohn’s disease management Kate Burba
- Aldafermin 3 mg significantly reduced Enhanced Liver Fibrosis score in MASH Kate Burba
- ENLIVEN extension topline data: Pegozafermin sustains ‘robust benefits’ in NASH at week 48
- FDA grants fast track status to monoclonal antibody for primary sclerosing cholangitis
- Joint statement calls for FDA to require drug trials to include people with obesity
- Low-dose aspirin ‘potential therapeutic option’ for MASLD, markedly reduces steatosis Monica Stonehill
- On-demand vonoprazan may replace daily therapy for nonerosive reflux disease Kate Burba
- Pegozafermin improves stage 4 fibrosis, noninvasive markers in MASH patients Monica Stonehill
-
- ‘Small difference’ in colorectal neoplasia recurrence at 5 vs. 10 years after polypectomy Kate Burba
- Triple combination therapy ‘superior to monotherapy,’ improves remission in Crohn’s Kate Burba
- Up to 67% of patients achieve MASH resolution at 36 weeks with efruxifermin Kate Burba
- VIDEO: Flexible parental leave policies increase inclusivity, reduce burnout in GI Kate Burba